Skip to content

Prospective cohort study of the TCM (Traditional Chinese Medicine) comprehensive intervention of for the recovery phase of cerebral infarction

Clinical efficacy research of the TCM comprehensive intervention for recovery phase of ischemic stroke

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNRC-07000035
Enrollment
Unknown
Registered
2007-12-19
Start date
2007-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The recovery phase of ischemic stroke

Interventions

Acupuncture group:Acupncture with traditional Chinese herbal medicine, and massage (Tuina)

Sponsors

Shu Wang (The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. In accordance of the diagnosis in both Western and Traditional Chinese Medicine; 2. In the recovery phase of stroke: between 15 days and 6 months after the onset; 3. Blood supplying of the foci is from the inner carotid arteries system, and presenting the relative symptoms and signs; 4. Aged between 40 and 75 years old; 5. First onset; 6. Willing to take part in the trial and informed consents are obtained.

Exclusion criteria

Exclusion criteria: 1. Patients with conscious disorder or language comprehension disorder and cannot express themselves; 2. Large area of cerebral infarction (> 2/3*volume); 3. Systolic pressure higher than 180 mmHg or diastolic pressure higher than 130 mmHg after drugs treatment; 4. Combined with heart failure, hepatic and renal dysfunction (ALT >1.5*normal value, Cr >upper normal limit) or primary hematological diseases; 5. Cerebral embolism caused by rheumatic heart disease, coronary heart disease with atrial fibrillation confirmed by examinations; 6. Pregnant or breast-feeding women; 7. Patients with psychotic diseases that cannot cooperate; 8. Patients that are taking part in other clinical trials or participated in other trials within the latest 3 months.

Design outcomes

Primary

MeasureTime frame
Rate of cardiocerebral vascular event;

Secondary

MeasureTime frame
Motive function;

Countries

China

Contacts

Public ContactShu Wang
wangshu2002@hotmail.com+86 022 13803041034

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026